Tag: Anaconda Biomed
Anaconda Biomed receives CE-mark certification for ANA5 funnel catheter
Anaconda Biomed has today announced that it has received CE-mark certification for its ANA5 funnel catheter. The CE marking confirms that the ANA5 device...
Anaconda Biomed announces publication of ANAIS study
Anaconda Biomed has announced that results of the ANAIS study, which evaluated the safety and performance of its Ana funnel catheter in the endovascular...
Anaconda begins enrolment in ATHENA trial with first US patient treatment
Anaconda Biomed has announced the enrolment and treatment of the first US patient by Shahram Majidi (Mount Sinai, New York, USA) in its ATHENA...
Anaconda Biomed appoints Trent Reutiman as new CEO
Anaconda Biomed has announced that it has named long-time medtech executive Trent Reutiman as its new chief executive officer (CEO).
A press release details that, based...
Anaconda Biomed receives IDE approval to initiate enrolment in ATHENA study
Anaconda Biomed has announced that it has received conditional investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin...
Anaconda Biomed granted additional patents for novel stroke thrombectomy technology
Anaconda Biomed has announced that the European Patent Office has granted the company a European patent for “A device and a thrombectomy apparatus for...
